- Home
- NECB vs PROK Comparison
NECB vs PROK Comparison
Compare NECB & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NECB | PROK |
|---|---|---|
| Founded | 1934 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 310.9M | 331.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NECB | PROK |
|---|---|---|
| Price | $24.88 | $1.87 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $7.40 |
| AVG Volume (30 Days) | 55.6K | ★ 1.1M |
| Earning Date | 01-28-2026 | 03-16-2026 |
| Dividend Yield | ★ 4.04% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.25 | N/A |
| Revenue | ★ $104,927,000.00 | $744,000.00 |
| Revenue This Year | $9.76 | $956.51 |
| Revenue Next Year | $11.94 | N/A |
| P/E Ratio | $7.62 | ★ N/A |
| Revenue Growth | ★ 0.09 | N/A |
| 52 Week Low | $19.27 | $0.46 |
| 52 Week High | $25.49 | $7.13 |
Technical Indicators
Market Signals| Indicator | NECB | PROK |
|---|---|---|
| Relative Strength Index (RSI) | 69.74 | 35.78 |
| Support Level | $24.35 | $1.71 |
| Resistance Level | $25.18 | $2.18 |
| Average True Range (ATR) | 0.70 | 0.14 |
| MACD | 0.15 | -0.04 |
| Stochastic Oscillator | 86.71 | 20.35 |
Price Performance
Historical ComparisonAbout NECB NorthEast Community Bancorp Inc.
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.